Alexandra Friedrich

Title: Alexandra Friedrich: Innovator in Glucose Regulation

Introduction

Alexandra Friedrich is a prominent inventor based in Würzburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the area of glucose regulation. Her innovative work focuses on developing peptides that can enhance insulin sensitivity and regulate glucose absorption.

Latest Patents

Alexandra Friedrich holds a patent for her invention titled "Peptides derived from RS1 which down-regulate glucose absorption after a glucose-rich meal and increase insulin sensitivity." This patent describes a pharmaceutical composition that includes a (poly)peptide, which can be used in the prevention or treatment of diseases associated with glucose and galactose uptake. The invention also outlines methods for screening compounds that can modulate glucose absorption and predict patient responses to treatment.

Career Highlights

Friedrich is affiliated with Julius-Maximilians-Universität Würzburg, where she conducts her research. Her work has garnered attention for its potential impact on treating conditions related to glucose metabolism. With her innovative approach, she aims to improve the quality of life for individuals affected by these disorders.

Collaborations

Some of her notable collaborators include Jürgen Groll and Hermann Koepsell. Their combined expertise contributes to the advancement of research in glucose regulation and related fields.

Conclusion

Alexandra Friedrich is a trailblazer in the development of pharmaceutical solutions for glucose regulation. Her innovative patents and collaborative efforts highlight her commitment to advancing medical science.